European Journal of Cancer
Volume 37, Issue 3 , Pages 422-430 , February 2001

Treatment of hepatocellular carcinoma in a rat model using electrochemotherapy

  • M.J Jaroszeski

      Affiliations

    • Department of Surgery, College of Medicine, University of South Florida, 12901 Bruce B. Downs Boulevard, Tampa, FL 33612-4799, USA
    • Center for Molecular Delivery, University of South Florida, Tampa, FL, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-813-974-4662; fax: +1-813-974-2669
    • ,
  • D Coppola

      Affiliations

    • G.I. Tumor Program, Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA
    • Department of Pathology, College of Medicine, MDC 11, University of South Florida, 12901 Bruce B. Downs Boulevard, Tampa, FL 33612, USA
    • ,
  • C Pottinger

      Affiliations

    • Department of Surgery, College of Medicine, University of South Florida, 12901 Bruce B. Downs Boulevard, Tampa, FL 33612-4799, USA
    • ,
  • K Benson

      Affiliations

    • Department of Pathology, College of Medicine, MDC 11, University of South Florida, 12901 Bruce B. Downs Boulevard, Tampa, FL 33612, USA
    • ,
  • R.A Gilbert

      Affiliations

    • Center for Molecular Delivery, University of South Florida, Tampa, FL, USA
    • College of Engineering, ENB 118, University of South Florida, 4202 E. Fowler Avenue, Tampa, FL 33620, USA
    • ,
  • R Heller

      Affiliations

    • Department of Surgery, College of Medicine, University of South Florida, 12901 Bruce B. Downs Boulevard, Tampa, FL 33612-4799, USA
    • Center for Molecular Delivery, University of South Florida, Tampa, FL, USA
    • Cutaneous Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
    • Department of Medical Microbiology, University of South Florida, Tampa, FL, USA

Received 2 May 2000 ,Revised 29 September 2000 ,Accepted 2 October 2000.

References 

  1. Venook AP. Treatment of hepatocellular carcinoma: too many options?. J. Clin. Oncol. 1994;12(6):1323–1334
  2. American Cancer Society Inc . Cancer. Facts and Figures  — 1997. New York: American Cancer Society; 1997;
  3. Beasley RP. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma — epidemiologic considerations. Hepatology. 1982;2(2):21S–26S
  4. Lotze MTL, Flickinger JC, Carr BI. Hepatobiliary neoplasms. In:  DeVita VT,  Hellman S,  Rosenberg SA editor. Cancer, Principles & Practice Of Oncology. 4th edn. Philadelphia: J.B. Lippincot; 1993;p. 883–914
  5. Ikeda K, Saitoh S, Koida I, et al.  A multivariate analysis of risk factors for hepatocellular carcinogenesis (a prospective observation of 795 patients with viral and alcoholic cirrhosis). Hepatology. 1993;18(1):47–53
  6. Liu CL, Fan ST. Nonresectional therapies for hepatocellular carcinoma. Am. J. Surg. 1997;173:358–365
  7. Engstrom PE, Persson BRR, Salford LG. Dynamic gamma camera studies of 111In-bleomycin complex in normal and glioma bearing rats after in vivo electropermeabilization using exponential high-voltage pulses. Biolelectrochem. Bioenerget. 1998;46:241–248
  8. Belehradek J, Orlowski S, Ramirez LH, Pron G, Poddevin B, Mir LM. Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomcyin. Biochim. Biophys. Acta. 1994;1190:155–163
  9. Jaroszeski MJ, Gilbert R, Heller R. In vivo antitumor effects of electrochemotherapy in a hepatoma model. Biochim. Biophys. Acta. 1997;1334:15–18
  10. Pendez S, Jaroszeski MJ, Gilbert R, Hyacinthe M, et al.  Direct delivery of chemotherapeutic agents for the treatment of hepatomas and sarcomas in rat models. Radiol. Oncol. 1998;21(1):53–64
  11. Ramirez LH, Orlowski S, An D, et al.  Electrochemotherapy on liver tumours in rabbits. Br. J. Cancer. 1998;77(12):2104–2111
  12. Chazal M, Benchimol D, Baque P, Pierrefite V, Milano G, Bourgeon A. Treatment of hepatic metastases of colorectal cancer by electrochemotherapy (an experimental study in the rat). Surgery. 1998;124(3):536–540
  13. Heller R, Jaroszeski M, Leo-Messina J, et al.  Treatment of B16 melanoma with the combination of electroporation and chemotherapy. Bioelectrochem. Bioenerget. 1995;36:83–87
  14. Heller R, Jaroszeski M, Perrott R, Messina J, Gilbert R. Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy. Melanoma Res. 1997;7:10–18
  15. Mir LM, Orlowski S, Belehradek J, Paoletti C. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur. J. Cancer. 1991;27(1):68–72
  16. Sersa G, Novakovic S, Miklavcic D. Potentiation of bleomycin antitumor effectiveness by electrotherapy. Cancer Lett. 1993;69:81–84
  17. Sersa G, Cemazar M, Miclavcic D, Mir LM. Electrochemotherapy: variable anti-tumor effect on different tumor models. Bioelectrochem. Bioenerget. 1994;35:23–27
  18. Hyacinthe M, Jaroszeski MJ, Dang VV, et al.  Electrically enhanced drug delivery for the treatment of soft tissue sarcoma. Cancer. 1999;85(2):409–417
  19. Belehradek J, Orlowski S, Poddevin B, Paoletti C, Mir LM. Electrochemotherapy of spontaneous mammary tumors in mice. Eur. J. Cancer. 1991;27(1):73–76
  20. Heller R, Jaroszeski MJ, Glass LF, et al.  Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer. 1996;77(5):964–971
  21. Heller R, Jaroszeski MJ, Reintgen DS, et al.  Treatment of cutaneous tumors with electrochemotherapy using intralesional bleomcyin. Cancer. 1998;83(1):148–157
  22. Belehradek M, Domenge C, Luboinnski B, Orlowski S, Belehradek J, Mir LM. Electrochemotherapy, a new antitumor treatment. Cancer. 1993;72(12):3694–3700
  23. Domenge C, Orlowski S, Luboinski B, et al.  Antitumor electrochemotherapy. Cancer. 1996;77(5):956–963
  24. Rudolf Z, Stabuc B, Cemazar M, Miklavcic D, Vodovnik L, Sersa G. Electrochemotherapy with bleomycin. The first clinical experience in malignant melanoma patients. Radiol. Oncol. 1995;29:229–235
  25. Sersa G, Stabuc B, Cemazar M, Jancar B, Miklavcic D, Rudolf Z. Electrochemotherapy with cisplatin (potentiation of local Cisplatin antitumor effectiveness by application of electric pulses in cancer patients). Eur. J. Cancer. 1998;34(8):1213–1218
  26. Mir LM, Glass LF, Sersa G, et al.  Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br. J. Cancer. 1998;77(12):2336–2342
  27. Jaroszeski MJ, Coppola D, Nesmith G, et al. Effects of electrochemotherapy with bleomycin on normal liver tissue in a rat model. Eur J Cancer, 2001, 37, 414–421.
  28. Gilbert RA, Jaroszeski MJ, Heller R. Novel electrode designs for electrochemotherapy. Biochim. Biophys. Acta. 1997;1334:9–14
  29. Jaroszeski MJ, Gilbert R, Heller R. Electrochemotherapy: an emerging drug delivery method for the treatment of cancer. Adv. Drug Deliv. Rev. 1997;26:185–197
  30. Mir LM, Orlowski S, Poddevin B, Belehradek J. Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses. Eur. Cytokene Netw. 1992;3(3):331–334
  31. Mir LM, Roth C, Orlowski S, et al.  Systemic antitumor effects of electrhchemotherapy combined with histoincompatible cell secreting interleukin-2. J. Immunother. 1997;17:30–38

PII: S0959-8049(00)00412-3

European Journal of Cancer
Volume 37, Issue 3 , Pages 422-430 , February 2001

Article Tools

* Image Usage & Resolution